Literature DB >> 21956831

Combined antidepressant strategies are not more effective than vigorous escitalopram monotherapy: results of the CO-MED study.

Michael E Thase1.   

Abstract

Entities:  

Year:  2011        PMID： 21956831     DOI： 10.1007/s11920-011-0236-9

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


× No keyword cloud information.
  9 in total

1.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

Review 2.  Antidepressant combinations: widely used, but far from empirically validated.

Authors:  Michael E Thase
Journal:  Can J Psychiatry       Date:  2011-06       Impact factor: 4.356

3.  The search for improved antidepressant strategies: is bigger better?

Authors:  William Coryell
Journal:  Am J Psychiatry       Date:  2011-07       Impact factor: 18.112

Review 4.  Strategies to achieve clinical effectiveness: refining existing therapies and pursuing emerging targets.

Authors:  Sidney H Kennedy; Allan H Young; Pierre Blier
Journal:  J Affect Disord       Date:  2011-05-14       Impact factor: 4.839

Review 5.  Managing depressive and anxiety disorders with escitalopram.

Authors:  Michael E Thase
Journal:  Expert Opin Pharmacother       Date:  2006-03       Impact factor: 3.889

6.  Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.

Authors:  Pierre Blier; Herbert E Ward; Philippe Tremblay; Louise Laberge; Chantal Hébert; Richard Bergeron
Journal:  Am J Psychiatry       Date:  2009-12-15       Impact factor: 18.112

7.  Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.

Authors:  Pierre Blier; Gabriella Gobbi; Julie E Turcotte; Claude de Montigny; Nathalie Boucher; Chantal Hébert; Guy Debonnel
Journal:  Eur Neuropsychopharmacol       Date:  2009-04-02       Impact factor: 4.600

8.  Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials.

Authors:  J Craig Nelson; George I Papakostas
Journal:  Am J Psychiatry       Date:  2009-08-17       Impact factor: 18.112

9.  Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.

Authors:  J Craig Nelson; Carolyn M Mazure; Peter I Jatlow; Malcolm B Bowers; Lawrence H Price
Journal:  Biol Psychiatry       Date:  2004-02-01       Impact factor: 13.382
  9 in total
  1 in total

1.  Effectiveness of Duloxetine Monotherapy Compared to Combination Therapy with Other Antidepressants in Patients with Major Depressive Disorder: A Short-Term, Retrospective Study.

Authors:  Eun-Jin Cheon; Jun-Yeob Lee; Joong-Hyeon Choi; Young-Ji Lee; Bon-Hoon Koo
Journal:  Psychiatry Investig       Date:  2016-07-25       Impact factor: 2.505
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.